Rigel Pharmaceuticals wins early cancer drug approval, lines up new HQ - San Francisco Business Times

Longtime biotech Rigel Therapeutics Inc. has a newly approved blood cancer drug and, come next month, it will have a new home.

Rigel next month is expected to move its headquarters to 13,670 square feet of office space at 611 Gateway Blvd., subleased from Atara Biotherapeutics Inc. . The sublease, which runs into May 2025 at under $50 per square foot, is less than a mile from Rigel's longtime home at 1180 Veterans Boulevard, where it occupies about 81,000 square feet.

The drug will carry a warning for"differentiation syndrome," a sometimes-fatal group of severe reactions by acute myeloid leukemia patients to a drug.

Brasil Últimas Notícias, Brasil Manchetes

Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.

Eche Martinez is building a thriving interior design business in San Francisco - San Francisco Business TimesFor Eche Martinez interior design is more than a job. Here he takes us inside his thriving practice and shares his design secrets.
Fonte: SFBusinessTimes - 🏆 78. / 68 Consulte Mais informação »

Napa Valley's Seven Stones Estate and Winery sells for $34 million - San Francisco Business TimesThe 45-acre Napa Valley property includes a 6,600-square-foot main residence, vineyard and winery. Here are the new plans for the site.
Fonte: SFBusinessTimes - 🏆 78. / 68 Consulte Mais informação »

Wells Fargo issues more layoffs in mortgage business - San Francisco Business TimesMore layoffs around the country have reportedly hit San Francisco-based Wells Fargo
Fonte: SFBusinessTimes - 🏆 78. / 68 Consulte Mais informação »